Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angeion Corporation
Angeion Corporation Reports First Quarter Results
April 4th, 2008
Angeion Corporation (NASDAQ: ANGN) announced results for its first quarter ended January 31, 2008. For the quarter, Angeion reported a net loss of $675,000, or $0.17 per diluted share, on revenues of $7.5 million. This compares to net income of $489,000, or $0.12 per diluted share, on revenues of $10.6 million in the first quarter of last year. In its 2007 fourth quarter release, Angeion indicated that it expected revenues from its largest clinical research customer to be at a notably-reduced level in 2008 due to an unanticipated early end of the customer's clinical trial. This did indeed occur and revenue from this source totaled 6.7% of first...
Source: Health Business Week (2008-04-04)
|
